In Brief: FDA 510(k) fax policy
This article was originally published in The Gray Sheet
FDA 510(k) fax policy: Beginning May 15, FDA will notify sponsors by fax as well as by mail whether a 510(k) is deemed "substantially equivalent" or "not substantially equivalent," provided a fax number is included with the premarket submission. The fax will be sent within one business day after the agency mails its decision, according to FDA staffers...
You may also be interested in...
Novartis has long championed the idea of making Sandoz an autonomous unit within the Swiss originator while stopping short of carving out the business altogether. Rumors continue to swirl around a potential deal, which was discussed during the recent virtual Meet Novartis Management event.
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.